Refine Search
(5)
(8)
(8)
(8)

Immunology

More than 65% of pipeline drugs are in early stages of development. Tumor necrosis factor, B lymphocyte antigen CD20 and nuclear receptor ROR gamma are some of the major targets under research for immunological diseases.

Liver Transplant Rejection - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Liver Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Liver Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Bone Marrow Transplant Rejection - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Grass Pollen Allergy - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2018’, provides an overview of the Grass Pollen Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gras...

Rheumatoid Arthritis - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2018’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rheu...

Heart Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Heart Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Heart Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Lung Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lung Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Lung Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Peanut Allergy - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H1 2018’, provides an overview of the Peanut Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peanut Allergy, ...

Kidney Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Kidney Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...